Advertisement

Meta-analysis of C-Reactive Protein and Risk of Angina Pectoris

Published:January 07, 2020DOI:https://doi.org/10.1016/j.amjcard.2020.01.005

      Highlights

      • Elevated CRP levels were associated with angina pectoris.
      • Patients with angina pectoris syndromes can probably be prediagnosed by their levels of CRP.
      • CRP levels may be a risk factor of major adverse cardiac event.
      Associations between elevated C-reactive protein (CRP) levels and the angina pectoris risk have been reported for many years, but the results remain controversial. To address this issue, a meta-analysis was therefore conducted. Eligible studies were identified by searching PubMed, EMBASE, Cochrane library, and web of science up to January 2019. Altogether, 10 prospective cohort studies and 11 case-control studies were included, and they were published from 1997 to 2013 and summed up to 18,316 samples totally. The pooled mean difference of CRP levels was 4.44 (95% confidence interval 2.71 to 6.17) between angina patients and healthy controls. The combined odds ratio of CRP for major adverse cardiac events in angina patients was 1.67 (95% CI 1.23 to 2.26). In conclusion, the meta-analysis indicated that elevated CRP levels were associated with angina pectoris, especially unstable angina pectoris, and were probably a risk factor of major adverse cardiac events.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • World Health Organization
        The Atlas of Heart Disease and Stroke.
        World Health Organization, 2004
        • Mahmoud FA
        • Rivera NI
        The role of C-reactive protein as a prognostic indicator in advanced cancer.
        Curr Oncol Rep. 2002; 4: 250-255
        • Pepys MB
        C-reactive protein and the acute phase response.
        Nature. 1982; 296: 12
        • Liberati A
        • Altman DG
        • Tetzlaff J
        • Mulrow C
        • Gotzsche PC
        • Ioannidis JP
        • Clarke M
        • Devereaux PJ
        • Kleijnen J
        • Moher D
        The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration.
        BMJ. 2009; 339: b2700
        • Al-Karkhi IH
        • Ibrahim AE
        • Yaseen AK
        Levels of insulin, IL-6 and CRP in patients with unstable angina.
        Adv Clin Exp Med. 2013; 22: 655-658
        • Angiolillo DJ
        • Liuzzo G
        • Pelliccioni S
        • De Candia E
        • Landolfi R
        • Crea F
        • Maseri A
        • Biasucci LM
        Combined role of the Lewis antigenic system, Chlamydia pneumoniae, and C-reactive protein in unstable angina.
        J Am Coll Cardiol. 2003; 41: 546-550
        • Avanzas P
        • Arroyo-Espliguero R
        • Cosin-Sales J
        • Quiles J
        • Zouridakis E
        • Kaski JC
        Multiple complex stenoses, high neutrophil count and C-reactive protein levels in patients with chronic stable angina.
        Atherosclerosis. 2004; 175: 151-157
        • Azar RR
        • Aoun G
        • Fram DB
        • Waters DD
        • Wu AH
        • Kiernan FJ
        Relation of C-reactive protein to extent and severity of coronary narrowing in patients with stable angina pectoris or abnormal exercise tests.
        Am J Cardiol. 2000; 86: 205-207
        • Benamer H
        • Steg PG
        • Benessiano J
        • Vicaut E
        • Gaultier CJ
        • Boccara A
        • Aubry P
        • Nicaise P
        • Brochet E
        • Juliard JM
        • Himbert D
        • Assayag P
        Comparison of the prognostic value of C-reactive protein and troponin I in patients with unstable angina pectoris.
        Am J Cardiol. 1998; 82: 845-850
        • Eschen O
        • Christensen JH
        • Johnsen SP
        • Dethlefsen C
        • Schmidt EB
        Adhesion molecules and C-reactive protein are associated to adverse events in angina pectoris.
        Scand Cardiovasc J. 2010; 44: 153-160
        • Ford ES
        • Giles WH
        Serum C-reactive protein and fibrinogen concentrations and self-reported angina pectoris and myocardial infarction: findings from National Health and Nutrition Examination Survey III.
        J Clin Epidemiol. 2000; 53: 95-102
        • Garcia-Moll X
        • Zouridakis E
        • Cole D
        • Kaski JC
        C-reactive protein in patients with chronic stable angina: differences in baseline serum concentration between women and men.
        Eur Heart J. 2000; 21: 1598-1606
        • Haverkate F
        • Thompson SG
        • Pyke SD
        • Gallimore JR
        • Pepys MB
        Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group.
        Lancet. 1997; 349: 462-466
        • Heeschen C
        • Hamm CW
        • Bruemmer J
        • Simoons ML
        Predictive value of C-reactive protein and troponin T in patients with unstable angina: a comparative analysis. CAPTURE Investigators. Chimeric c7E3 AntiPlatelet Therapy in Unstable angina REfractory to standard treatment trial.
        J Am Coll Cardiol. 2000; 35: 1535-1542
        • Hoffmeister HM
        • Ehlers R
        • Buttcher E
        • Kazmaier S
        • Szabo S
        • Beyer ME
        • Steinmetz A
        • Seipel L
        Comparison of C-reactive protein and terminal complement complex in patients with unstable angina pectoris versus stable angina pectoris.
        Am J Cardiol. 2002; 89: 909-912
        • Koo BK
        • Choi D
        • Kyung HD
        • Jang Y
        • Shim WH
        • Cho SY
        C-reactive protein in stable angina patients without peripheral vascular disease.
        Int J Cardiol. 2003; 88: 105-106
        • Li JJ
        • Jiang H
        • Huang CX
        • Fang CH
        • Tang QZ
        • Xia H
        • Liu J
        • Li GS
        Elevated level of plasma C-reactive protein in patients with unstable angina: its relations with coronary stenosis and lipid profile.
        Angiology. 2002; 53: 265-272
        • Luo Y
        • Jiang D
        • Wen D
        • Yang J
        • Li L
        Changes in serum interleukin-6 and high-sensitivity C-reactive protein levels in patients with acute coronary syndrome and their responses to simvastatin.
        Heart Vessels. 2004; 19: 257-262
        • Tomai F
        • Crea F
        • Gaspardone A
        • Versaci F
        • Ghini AS
        • Chiariello L
        • Gioffre PA
        Unstable angina and elevated c-reactive protein levels predict enhanced vasoreactivity of the culprit lesion.
        Circulation. 2001; 104: 1471-1476
        • Ulucay A
        • Demirbag R
        • Yilmaz R
        • Unlu D
        • Gur M
        • Selek S
        • Celik H
        The relationship between plasma C-reactive protein levels and presence and severity of coronary stenosis in patients with stable angina.
        Angiology. 2007; 58: 657-662
        • Wang HY
        • Gao PJ
        • Ji KD
        • Shen WF
        • Fan CL
        • Lu L
        • Zhu DL
        Circulating endothelial progenitor cells, C-reactive protein and severity of coronary stenosis in Chinese patients with coronary artery disease.
        Hypertens Res. 2007; 30: 133-141
        • Wettero J
        • Nilsson L
        • Jonasson L
        • Sjowall C
        Reduced serum levels of autoantibodies against monomeric C-reactive protein (CRP) in patients with acute coronary syndrome.
        Clin Chim Acta. 2009; 400: 128-131
        • Yamashita H
        • Shimada K
        • Seki E
        • Mokuno H
        • Daida H
        Concentrations of interleukins, interferon, and C-reactive protein in stable and unstable angina pectoris.
        Am J Cardiol. 2003; 91: 133-136
        • Zebrack JS
        • Anderson JL
        • Maycock CA
        • Horne BD
        • Bair TL
        • Muhlestein JB
        Usefulness of high-sensitivity C-reactive protein in predicting long-term risk of death or acute myocardial infarction in patients with unstable or stable angina pectoris or acute myocardial infarction.
        Am J Cardiol. 2002; 89: 145-149
        • Zebrack JS
        • Muhlestein JB
        • Horne BD
        • Anderson JL
        C-reactive protein and angiographic coronary artery disease: independent and additive predictors of risk in subjects with angina.
        J Am Coll Cardiol. 2002; 39: 632-637
        • Mulvihill NT
        • Foley JB
        Inflammation in acute coronary syndromes.
        Heart. 2002; 87: 201-204
        • Kuller LH
        • Tracy RP
        • Shaten J
        • Meilahn EN
        Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial.
        Am J Epidemiol. 1996; 144: 537-547
        • Ridker PM
        • Cushman M
        • Stampfer MJ
        • Tracy RP
        • Hennekens CH
        Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men.
        N Engl J Med. 1997; 336: 973-979
        • Tracy RP
        • Lemaitre RN
        • Psaty BM
        • Ives DG
        • Evans RW
        • Cushman M
        • Meilahn EN
        • Kuller LH
        Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project.
        Arterioscler Thromb Vasc Biol. 1997; 17: 1121-1127
        • van der Wal AC
        • Becker AE
        • van der Loos CM
        • Das PK
        Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology.
        Circulation. 1994; 89: 36-44